Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease

被引:2
|
作者
Zhang, Hong-Da [1 ]
Yan, Yi [2 ,3 ]
He, Yang-Yang [4 ]
Liu, Qian-Qian [1 ]
Peng, Fu-Hua [1 ]
Yan, Xin-Xin [1 ]
Han, Zhi-Yan [1 ,5 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
[2] Shanghai Jiao Tong Univ, Heart Ctr, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200127, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Inst Pediat Congenital Heart Dis, Sch Med, Shanghai 200127, Peoples R China
[4] Henan Univ, Sch Pharm, Kaifeng 475004, Peoples R China
[5] Fuwai Hosp, Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Dept Anesthesiol,State Key, 167 Beilishi Rd, Beijing 100037, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Pulmonary arterial hypertension; Congenital heart disease; Exercise intolerance; Cardiopulmonary exercise testing; Peak oxygen uptake; EISENMENGER SYNDROME; ADULTS; SURVIVAL; ERA;
D O I
10.1016/j.ijcard.2022.12.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Exercise intolerance is a major manifestation of pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). We aimed to investigate the characteristics of exercise intolerance in different subgroups of PAH-CHD. Methods: We retrospectively enrolled 171 adult patients with PAH-CHD and 30 age and sex-matched healthy subjects and performed cardiopulmonary exercise testing. Gas exchange parameters, including peak oxygen uptake (peak VO2), anaerobic threshold, and the slope of ventilatory equivalent for carbon dioxide (VE/VCO2 slope), were recorded. Results: The median age of patients at enrollment was 27.8 years, and 131 (76.6%) were female. Peak VO2 was reduced in patients compared to healthy controls (median, 14.8 ml/kg/min versus 26.9 ml/kg/min, p < 0.001). Of all 171 patients, 60 (35.1%) had Eisenmenger syndrome, 35 (20.5%) had PAH associated with systemic-to-pulmonary shunts (PAH-SP), 39 (22.8%) had PAH with small defects (PAH-SD), and 37 (21.6%) had PAH after cardiac defect correction (PAH-CD). Patients with Eisenmenger syndrome had the lowest peak VO2 (p = 0.003) and the highest VE/VCO2 slope (p = 0.012), compared with other patients, representing the worst exercise capacity and ventilatory efficiency. Patients with PAH-SP had the best exercise capacity among the four groups, indicated by the highest peak VO2 (p = 0.003) compared with other patients. Peak VO2 was negatively correlated with pulmonary vascular resistance (r =-0.411, p < 0.001). Conclusions: Exercise capacity was severely reduced in patients with PAH-CHD. Among the four subgroups, patients with Eisenmenger syndrome had the worst exercise capacity and ventilatory efficiency.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
  • [41] Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups
    Manes, Alessandra
    Palazzini, Massimiliano
    Leci, Enri
    Reggiani, Maria L. Bacchi
    Branzi, Angelo
    Galie, Nazzareno
    EUROPEAN HEART JOURNAL, 2014, 35 (11) : 716 - 724
  • [42] Pulmonary arterial hypertension in congenital heart disease: Current perspectives and future challenges
    Giannakoulas, George
    Gatzoulis, Michael A.
    HELLENIC JOURNAL OF CARDIOLOGY, 2016, 57 (04) : 218 - 222
  • [43] Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism
    Duffels, M. G. J.
    van der Plas, M. N.
    Surie, S.
    Winter, M. M.
    Bouma, B. J.
    Groenink, M.
    van Dijk, A. P. J.
    Hoendermis, E. S.
    Berger, R. M. F.
    Bresser, P.
    Mulder, B. J. M.
    NETHERLANDS HEART JOURNAL, 2009, 17 (09) : 334 - +
  • [44] Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry
    Chiu, Shuenn-Nan
    Weng, Ken-Pen
    Lin, Ming-Chih
    Wang, Jieh-Neng
    Hwang, Be-Tau
    Dai, Zen-Kong
    Lin, Shan-Miao
    Chang, Jeng-Sheng
    Lin, I-Chun
    Wu, Mei-Hwan
    Lu, Chun-Wei
    Lin, Ming-Tai
    Chen, Chun-An
    Hua, Yu-Chuan
    Wu, Jing-Ming
    Wang, Jou-Kou
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 317 : 49 - 55
  • [45] The Role of Genetics in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
    Canbeyli, Fatma Hayvaci
    Secgen, Kazim
    Ezgu, Fatih Suheyl
    Tacoy, Gulten
    Unlu, Serkan
    Arabaci, Hidayet Ozan
    Pektas, Ayhan
    Inci, Asli
    Kaya, Ergun Baris
    Sinan, Umit Yasar
    Kucukoglu, Mehmet Serdar
    Kula, Serdar
    PEDIATRIC CARDIOLOGY, 2025,
  • [46] Pulmonary hypertension and pulmonary circulation in congenital heart disease
    Schulze-Neick, I.
    Kaemmerer, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 : S170 - S172
  • [47] Pulmonary arterial hypertension in adult congenital heart disease
    Brida, Margarita
    Gatzoulis, Michael A.
    HEART, 2018, 104 (19) : 1568 - 1574
  • [48] Risk Stratification fi cation and Prognosis of Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Dong, Wenjie
    Hong, Zhibin
    Wang, Aqian
    Jiang, Kaiyu
    Zhu, Hai
    Zhang, Fu
    Guo, Zhaoxia
    Su, Hongling
    Cao, Yunshan
    CONGENITAL HEART DISEASE, 2024, 19 (03) : 325 - 339
  • [49] Pulmonary hypertension associated with congenital heart disease
    Beghetti, M.
    REVUE DES MALADIES RESPIRATOIRES, 2006, 23 : S49 - S59
  • [50] The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease
    van Dissel, Alexandra C.
    Mulder, Barbara J. M.
    Bouma, Berto J.
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (04)